Product Information
NORETHIND-ETH ESTRAD 1-0.02 MG is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1741 per EA under NDC 68462013281. Its NADAC has been published 520 times since Jul 13, 2016.
Strength
.02; 1 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462013281
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ETHINYL ESTRADIOL; NORETHINDRONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA206969On Market Since
1/20/2016
Price Statistics
The NADAC for NORETHIND-ETH ESTRAD 1-0.02 MG has been published 520 times since Jul 13, 2016, and over the history we have for it it has declined 77.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1741 per EA |
|---|---|
| All-time high | $0.7935 (Nov 16, 2016) |
| All-time low | $0.1619 (Nov 20, 2024) |
| 52-week high | $0.1797 |
| 52-week low | $0.1652 |
| Median price | $0.3254 |
| Average price | $0.3515 |
| Largest weekly change | +37.1% (May 22, 2019) |
| Weeks tracked | 520 |
| Tracking since | Jul 13, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Norethindrone Acetate and Ethinyl Estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of NORETHIND-ETH ESTRAD 1-0.02 MG?
The current National Average Drug Acquisition Cost (NADAC) for NORETHIND-ETH ESTRAD 1-0.02 MG, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1741 per EA (NDC 68462013281), effective Jun 24, 2026.
How has the price of NORETHIND-ETH ESTRAD 1-0.02 MG changed over time?
Over the history we have for it, the NADAC for NORETHIND-ETH ESTRAD 1-0.02 MG has declined 77.3%. It has been tracked across 520 weekly CMS publications since Jul 13, 2016.
What are the highest and lowest recorded NADAC prices for NORETHIND-ETH ESTRAD 1-0.02 MG?
Since Jul 13, 2016, the NADAC for NORETHIND-ETH ESTRAD 1-0.02 MG has ranged from a low of $0.1619 (Nov 20, 2024) to a high of $0.7935 (Nov 16, 2016), with a median of $0.3254 per EA.
Are there cheaper alternatives to NORETHIND-ETH ESTRAD 1-0.02 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of NORETHIND-ETH ESTRAD 1-0.02 MG, so no direct lower-cost alternative is listed.
Who manufactures NORETHIND-ETH ESTRAD 1-0.02 MG?
NORETHIND-ETH ESTRAD 1-0.02 MG (NDC 68462013281) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification